Status:
UNKNOWN
Tibial Nerve and Extracorporeal Magnetic Stimulation for Overactive Bladder
Lead Sponsor:
Pamukkale University
Conditions:
Idiopathic Overactive Bladder
Bladder Training
Eligibility:
FEMALE
18-90 years
Phase:
NA
Brief Summary
Overactive bladder (OAB) syndrome is urinary urgency, usually accompanied by frequency and nocturia, with or without urgency urinary incontinence, in the absence of urinary tract infection. For the tr...
Detailed Description
This study is a prospectively randomized, controlled trial. The trial will be held at Urogynecological Rehabilitation Unit of Pamukkale University, Physical Medicine and Rehabilitation Department betw...
Eligibility Criteria
Inclusion
- Women over the age of 18 with clinical diagnosis of idiopathic OAB Urodynamically confirmed detrusor overactivity (the presence of detrusor contractions in the filling phase of saline cystometry)
- Not tolerated or unresponsive to antimuscarinics and discontinued at least 4 weeks Able to give written, informed consent Able to understand the precedures, advantages and possible side effects Willing and able to complate the voiding diary and QoL questionnaire The strength of PFM 3/5 and more
Exclusion
- History of BT, MS therapy
- Pregnancy or intention to become pregnant during the study Current vulvovaginitis or urinary tract infections or malignancy
- More than stage 2 according to the pelvic organ prolapse quantification (POP-Q)
- Cardiac pacemaker, implanted defibrillator, coronary artery stent
- Ongoing treatment for arrhythmia
- Lower abdominal pain or dysmenorrhea
- yet to be diagnosed Electronic device or metallic implant applied to areas between the lumbar region and lower extremities
- Previous urogyneceological surgery within 3 months
- Ongoing surgical treatment or treatment with implantable devices for urinary incontinence or use of intrauterin copper devices
- Neurogenic bladder, signs of neurologic abnormalities at objective examination; history of the peripheral or central neurologic pathology
- Ultrasonographic evidence of PVR volume more than 100 ml
Key Trial Info
Start Date :
June 2 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 15 2022
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT05387824
Start Date
June 2 2022
End Date
November 15 2022
Last Update
November 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pamukkale University
Denizli, Kınıklı, Turkey (Türkiye), 20100